Silicon Motion Announces Results for the Period Ended December 31, 2017
Feb 06, 2018 23:00 pm UTC| Business
Financial Highlights 4Q 2017 GAAP4Q 2017 Non-GAAP Net sales $136.2 million (+7% Q/Q, -6% Y/Y)$136.2 million (+7% Q/Q, -6% Y/Y) Gross margin 46.5 %46.6 % Operating margin 10.0%24.1% Earnings per diluted ADS $0.27 ...
Feb 06, 2018 23:00 pm UTC| Business
VANCOUVER, British Columbia, Feb. 06, 2018 -- Madison Pacific Properties Inc. (TSX:MPC) (TSX:MPC.C) (the Company) reports that it has entered into a 50/50 joint venture with a residential developer to rezone and...
Teledyne Optech Titan lidar enables discovery of extended Mayan ruins in Guatemala
Feb 06, 2018 22:47 pm UTC| Business
VAUGHAN, Ontario, Feb. 06, 2018 -- Teledyne Optech’s Titan sensor was used by the University of Houston’s National Center for Airborne Laser Mapping (NCALM) to reveal extensive Mayan ruins in Guatemala. Lidar technology...
InterCloud announces a definitive agreement for the sale of a subsidiary
Feb 06, 2018 22:45 pm UTC| Business
NEW YORK, Feb. 06, 2018 -- InterCloud Systems, Inc. (the "Company" or "InterCloud") (OTC:ICLD), a leading provider of cloud networking orchestration and automation solutions and services, today announced the execution...
Hope Bancorp to Participate in 2018 KBW Winter Financial Services Symposium
Feb 06, 2018 22:40 pm UTC| Business
LOS ANGELES, Feb. 06, 2018 -- Hope Bancorp, Inc. (NASDAQ:HOPE) today announced that President and Chief Executive Officer Kevin Kim and Chief Financial Officer Alex Ko will be meeting with institutional investors at the...
Brookfield Residential Announces Acquisition of OliverMcMillan to Expand its Mixed-Use Business
Feb 06, 2018 22:34 pm UTC| Business
CALGARY, Alberta, Feb. 06, 2018 -- Brookfield Residential Properties Inc. today announced they have acquired the assets of national mixed-use developer OliverMcMillan. Joining forces with Brookfield Residential,...
MacroGenics to Participate in Two Upcoming Investor Conferences
Feb 06, 2018 22:30 pm UTC| Business
ROCKVILLE, MD, Feb. 06, 2018 -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...